Clinical & Experimental Immunology

Cover image for Vol. 183 Issue 2

Edited By: M. Peakman

Impact Factor: 3.037

ISI Journal Citation Reports © Ranking: 2014: 65/148 (Immunology)

Online ISSN: 1365-2249

Most Accessed

Top 20 downloaded articles, 2014

Read a selection of the top downloaded articles published in 2013 and 2014:

Myasthenia gravis: an update for the clinician
J. P. Sieb

New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin
R. Ameratunga, S.-T. Woon, D. Gillis, W. Koopmans, and R. Steele

CLIPPERS: chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids. Review of an increasingly recognized entity within the spectrum of inflammatory central nervous system disorders
A. Dudesek, F. Rimmele, S. Tesar, S. Kolbaske, P. S. Rommer, R. Benecke, and U. K. Zettl

Diagnosis, pathogenesis and treatment of myositis: recent advances
P. -O. Carstens, and J. Schmidt

Neuromyelitis optica: clinical features, immunopathogenesis and treatment
S. Jarius, B. Wildemann, and F. Paul

Ex-vivo whole blood secretion of interferon (IFN)-γ and IFN-γ-inducible protein-10 measured by enzyme-linked immunosorbent assay are as sensitive as IFN-γ enzyme-linked immunospot for the detection of gluten-reactive T cells in human leucocyte antigen (HLA)-DQ2·5+-associated coeliac disease
N. Ontiveros, J. A. Tye-Din, M. Y. Hardy, and R. P. Anderson

Paraneoplastic neurological syndromes
F. Leypoldt, and K.-P. Wandinger

Cerebral vasculitis in adults: what are the steps in order to establish the diagnosis? Red flags and pitfalls
P. Berlit, and M. Kraemer

The intestinal microbiome in type 1 diabetes
J. L. Dunne, E. W. Triplett, D. Gevers, R. Xavier, R. Insel, J. Danska, and M. A. Atkinson

Protein kinase inhibitors in the treatment of inflammatory and autoimmune diseases
H. Patterson, R. Nibbs, I. McInnes, and S. Siebert

Requirement for safety monitoring for approved multiple sclerosis therapies: an overview
P. S. Rommer, U. K. Zettl, B. Kieseier, H.-P. Hartung, T. Menge, E. Frohman, B. M. Greenberg, B. Hemmer, and O. Stüve

Molecular diagnosis of chronic granulomatous disease
D. Roos, and M. de Boer

Disease-modifying therapy in multiple sclerosis and chronic inflammatory demyelinating polyradiculoneuropathy: common and divergent current and future strategies
N. Melzer, and S. G. Meuth

Monoclonal antibodies in treatment of multiple sclerosis
P. S. Rommer, A. Dudesek, O. Stüve, and U.K. Zettl

Intestinal microbiota and faecal transplantation as treatment modality for insulin resistance and type 2 diabetes mellitus
S. D. Udayappan, A. V. Hartstra, G. M. Dallinga-Thie, and M. Nieuwdorp

Helminths in the hygiene hypothesis: sooner or later?
R. M. Maizels, H. J. McSorley, and D. J. Smyth

Microbial ‘old friends’, immunoregulation and socioeconomic status
G. A. W. Rook, C. L. Raison, and C. A. Lowry

Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now?
C. M. U. Hilkens, and J. D. Isaacs

Multiple sclerosis treatment and infectious issues: update 2013
A. Winkelmann, M. Loebermann, E. C. Reisinger, and U. K. Zettl

Promoting transplantation tolerance; adoptive regulatory T cell therapy
N. Safinia, J. Leech, M. Hernandez-Fuentes, R. Lechler, and G. Lombardi